Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

RenovoRx (RNXT) EPS (Weighted Average and Diluted) (2025)

Historic EPS (Weighted Average and Diluted) for RenovoRx (RNXT) over the last 1 years, with Q3 2025 value amounting to -$0.08.

  • RenovoRx's EPS (Weighted Average and Diluted) changed N/A to -$0.08 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.24, marking a year-over-year change of. This contributed to the annual value of -$0.48 for FY2024, which is N/A changed from last year.
  • As of Q3 2025, RenovoRx's EPS (Weighted Average and Diluted) stood at -$0.08.
  • RenovoRx's EPS (Weighted Average and Diluted)'s 5-year high stood at -$0.08 during Q1 2025, with a 5-year trough of -$0.08 in Q1 2025.